Home Coronavirus COVID-19 AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant AstraZeneca/Oxford Covid-19 Vaccine: “Limited Efficacy” Against South African Variant February 7, 2021 You are unauthorized to view this page. Username or E-mail Password Remember Me Forgot Password RELATED ARTICLESMORE FROM AUTHOR Survey: Mexican Views of the U.S. Have Deteriorated Sharply Under Trump U.S. to Impose 30% Tariff on Mexican Imports as Bilateral Talks Continue Boxer Julio César Chávez Jr. Arrested in U.S., Faces Extradition to Mexico Sinaloa Cartel Leader Ovidio Guzmán Pleads Guilty to Drug Trafficking in U.S. Court 1% U.S. Tax on Remittances Could Slash Mexican Household Spending by 25%, ANPEC Warns
